We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PREGABALIN ARW, PREGABALIN CW, PREGABALIN TIH (Arrow Pharma Pty Ltd)
Product name
PREGABALIN ARW, PREGABALIN CW, PREGABALIN TIH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 working days (255)
Active ingredients
pregabalin
Registration type
New generic medicine
Indication
PREGABALIN ARW, PREGABALIN CW, PREGABALIN TIH (capsules) are indicated for the treatment of neuropathic pain in adults.
PREGABALIN ARW, PREGABALIN CW, PREGABALIN TIH are indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.